Shenyang Xingqi Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
October 27, 2021 at 04:35 am EDT
Share
Shenyang Xingqi Pharmaceutical Co.,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 770.35 million compared to CNY 469.35 million a year ago. Revenue was CNY 770.35 million compared to CNY 469.35 million a year ago. Net income was CNY 156.07 million compared to CNY 53.73 million a year ago. Basic earnings per share from continuing operations was CNY 1.9 compared to CNY 0.65 a year ago. Diluted earnings per share from continuing operations was CNY 1.9 compared to CNY 0.65 a year ago.
SHENYANG XINGQI PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of ophthalmic drugs. The Companyâs main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The Company mainly distributes its products within domestic market.